Validation of POSSUM scoring systems for audit of major hepatectomy.

Utility of the Surgical Apgar Score in a district general hospital. World J Surg (2012) 1.00

Validation of the estimation of physiologic ability and surgical stress (E-PASS) score in liver surgery. World J Surg (2009) 0.94

A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery. HPB (Oxford) (2010) 0.86

Evaluation of POSSUM for patients undergoing pancreatoduodenectomy. World J Surg (2009) 0.83

Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma. World J Surg Oncol (2014) 0.79

Prospective evaluation of in-hospital mortality with the P-POSSUM scoring system in patients undergoing major digestive surgery. World J Surg (2012) 0.78

Comparison of P-POSSUM and O-POSSUM in predicting mortality after oesophagogastric resections. Postgrad Med J (2007) 0.78

Serum arterial lactate concentration predicts mortality and organ dysfunction following liver resection. Perioper Med (Lond) (2013) 0.77

Assessing surgical quality: comparison of general and procedure-specific morbidity estimation models for the risk adjustment of pancreaticoduodenectomy outcomes. World J Surg (2014) 0.75

Physiological and operative severity score for the enumeration of mortality and morbidity scoring systems for assessment of patient outcome and impact of surgeons' and anesthesiologists' performance in hepatopancreaticobiliary surgery. Saudi J Anaesth (2017) 0.75

Models predicting the risks of six life-threatening morbidities and bile leakage in 14,970 hepatectomy patients registered in the National Clinical Database of Japan. Medicine (Baltimore) (2016) 0.75

CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest (2000) 2.19

Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19

Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88

Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut (2003) 1.66

Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg (2004) 1.62

Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer (2006) 1.29

Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol (2013) 1.24

Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. Brain Res (1999) 1.12

SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol (2006) 1.07

Surgical treatment of pancreatic insulinomas in the era of laparoscopy. Surg Endosc (2004) 1.01

PIN1 expression contributes to hepatic carcinogenesis. J Pathol (2006) 1.00

Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther (2004) 0.98

Glycine conjugation activity of benzoic acid and its acinar localization in the perfused rat liver. J Pharmacol Exp Ther (1994) 0.92

Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and older. Aliment Pharmacol Ther (2004) 0.91

Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Am J Transplant (2007) 0.85

The impact of POSSUM score on the long-term outcome of patients with rectal cancer. Colorectal Dis (2013) 0.85

Liver transplantation for hepatocellular carcinoma. Br J Surg (2004) 0.83

Laparoscopic resection of a pancreatic polypeptidoma with a solitary liver metastasis. Surg Endosc (2004) 0.82

Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg (2004) 0.82

Galanin and the orexin 2 receptor as possible regulators of enkephalin in the paraventricular nucleus of the hypothalamus: relation to dietary fat. Neuroscience (2011) 0.80

48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection. Aliment Pharmacol Ther (2006) 0.78

Cellular uptake and metabolism of DNA frayed wires. Biochemistry (2003) 0.78

Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation. Am J Transplant (2006) 0.76

The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma. Biomed Pharmacother (2005) 0.76

Determination of acid phosphatase activity in normal human lymphocytes. Ann Clin Lab Sci (1982) 0.75

Enalaprilat handling by the kidney: barrier-limited cell entry. Am J Physiol (1992) 0.75

Rapamycin blocks the generation of regulatory T cells facilitated by posttransplant infusion of donor T cells through increasing the apoptosis of thymic CD4(+)CD25(+) cells. Transplant Proc (2002) 0.75

An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study. J Pharmacokinet Biopharm (1995) 0.75

Cytochemical localization of glycoconjugate in mitochondria. J Histochem Cytochem (1976) 0.75

The ultrastructural histochemistry of the basement membranes of the exocrine pancreas. Anat Rec (1977) 0.75